3Spine Announces 200 of 300 Patients Enrolled in Ongoing Studies

CHATTANOOGA, Tenn., March 30, 2023 /PRNewswire/ — 3Spine, Inc., today announced completion of the 50th MOTUS lumbar total joint replacement in the United States under FDA Investigational Device Exemption (IDE) and the 150th Real-World Evidence (RWE) lumbar fusion control case. This…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.